Mucofalk (Ispaghula Husk)

Ispaghula husk, the active ingredient in Mucofalk, is a bulk-forming laxative presented as an oral powder for oral use. It is used to relieve occasional constipation and to promote regular bowel movements in adults and children. GNH USA supplies Mucofalk as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mucofalk is a bulk‑forming laxative that works within the gastrointestinal tract to improve stool consistency and frequency. - Constipation: softens hard stools and facilitates easier passage. - Irregular bowel movements: increases stool bulk to stimulate peristalsis. - Functional constipation: helps maintain regularity without stimulating intestinal muscles directly.

Mucofalk is generally well tolerated, but some users may experience mild to moderate reactions.

Common Side Effects: - Bloating: sensation of abdominal fullness. - Flatulence: increased intestinal gas. - Abdominal cramps: mild, transient discomfort. - Diarrhoea: loose stools if excessive fiber is taken. - Nausea: occasional feeling of queasiness. - Increased thirst: due to higher water intake.

Serious or Rare Side Effects: - Intestinal obstruction: risk if underlying blockage exists. - Severe abdominal pain: may indicate a complication. - Rectal bleeding: possible with mucosal irritation. - Allergic reaction: rash, itching, or swelling. - Electrolyte imbalance: rare, especially with prolonged overuse. - Dehydration: excessive fluid loss from diarrhoea.

Before using Mucofalk, consider the following safety measures. - Adequate fluid intake: drink sufficient water to allow the fiber to swell properly. - Bowel obstruction: avoid use if a blockage or severe abdominal pain is suspected. - Start low: begin with a small dose and increase gradually as tolerated. - Monitor electrolytes: especially in elderly or patients on diuretics. - Store at ambient temperature: keep in the original pack, protect from moisture.

Mucofalk may affect the absorption of other oral medications.

Major Interactions (Avoid): - None identified: no major drug‑drug interactions have been reported for ispaghula husk. - Severe dehydration: may potentiate the effects of diuretics and increase risk of electrolyte disturbance.

Moderate Interactions (Monitor Closely): - Antibiotics (e.g., tetracycline, quinolones): fiber can reduce their absorption; separate dosing by at least 2 hours. - Antidiabetic agents: increased fibre may affect glucose control; monitor blood sugar. - Thyroid medication (levothyroxine): may impair absorption; advise spacing doses.